Led by Wellcome Leap CEO, Regina E. Dugan, who served as the 19th Director of DARPA, where she oversaw an annual $3B portfolio of projects ranging from hypersonics to RNA-based vaccines. An experienced Silicon Valley executive, she also built and led advanced project organizations at Google and Facebook.
Chaired by one of the most effective business leaders in the life sciences industry, Jay Flatley.
As CEO of Illumina, Jay helped to transform gene sequencing from a scientific pursuit to a commercially accessible service and moved the cost of sequencing an entire human genome from $1 million to $1,000.
Founded by visionaries Jeremy Farrar
, Mike Ferguson
, and the Wellcome Trust Leadership with a $300M seed investment, Wellcome Leap intends to assemble international partners such that together we create the critical mass of funding required.
Since founding, Wellcome Leap has welcomed COO, Ken Gabriel
, most recently the President and CEO of Draper, and expanded our global representation with Board member, Ho Ching
, former CEO of Temasek Holdings.